Northern Trust Corp Amneal Pharmaceuticals, Inc. Transaction History
Northern Trust Corp
- $586 Billion
- Q2 2024
A detailed history of Northern Trust Corp transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,252,852 shares of AMRX stock, worth $10.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,252,852
Previous 1,267,184
1.13%
Holding current value
$10.5 Million
Previous $7.68 Million
3.59%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding AMRX
# of Institutions
186Shares Held
137MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$182 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$117 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$103 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$94.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$89.5 Million2.02% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.26B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...